作者: Laísa Bonafim Negri , Tassia Joi Martins , Roberto Santana da Silva , Michael R. Hamblin
DOI: 10.1016/J.JPHOTOBIOL.2019.111564
关键词: Melanoma 、 Photodynamic therapy 、 Reactive oxygen species 、 Context (language use) 、 Photochemistry 、 Photosensitizer 、 Apoptosis 、 Chemistry 、 Nitric oxide 、 Singlet oxygen 、 Biophysics 、 Radiological and Ultrasound Technology 、 Radiation 、 Radiology Nuclear Medicine and imaging
摘要: Abstract Light irradiation has been used in clinical therapy for several decades. In this context, photobiomodulation (PBM) modulates signaling pathways via ROS, ATP, Ca2+, while photodynamic (PDT) generates reactive oxygen species by excitation of a photosensitizer. NO generation could be an important tool when combined with both kinds light therapy. By using metal-based compound, we found that PBM PDT beneficial cancer treatment option. We two types ruthenium compounds, ([Ru(Pc)], Pc = phthalocyanine) and trans-[Ru(NO)(NO2)(Pc)]. The UV–vis spectra complexes displayed band the 660 nm region. case 0.5 μM trans-[Ru(NO)(NO2)(Pc)], at Q-band reduced percentage viable human melanoma (A375) cells to around 50% as compared [Ru(Pc)]. hypothesized these results were due synergistic effect between singlet nitric oxide. Similar experiments performed (660 nm) (850 nm) induced more photocytotoxicity [Ru(Pc)] This was interpreted increasing cell metabolism (ATP production) consequent higher uptake phthalocyanine compounds efficient apoptosis. use photosensitizers may represent advance field